Highest-materiality recent filing
Agape ATP regains Nasdaq minimum bid price compliance; delisting hearing cancelled
Received Nasdaq notice on Mar 10, 2026, that bid price compliance restored under Rule 5550(a)(2).
Agape ATP announces 1-for-50 reverse stock split effective Feb 9, 2026
Reverse split ratio of 1-for-50; effective February 9, 2026; split-adjusted trading begins February 10, 2026 on Nasdaq.
Agape ATP receives Nasdaq delisting notice for low stock price; plans to appeal
Received delisting notice on Feb 2, 2026 under Low Priced Stocks rule (bid ≤ $0.10 for 10 days).
Agape ATP shareholders approve 60x increase in authorized shares and reverse split up to 1:5000
Authorized shares increased from 500M to 30B; approved with 30,073,422 for, 22,106 against.
Received Nasdaq notice Jan 27, 2026 for failing $1.00 minimum bid price based on closing bid Dec 10, 2025–Jan 26, 2026.
Agape ATP signs $24B supply agreements for jet fuel and diesel with Swiss One Oil & Gas
Aggregate SPA value approx $24B for 12-month supply of Jet Fuel A1 and EN590 diesel to Swiss One Oil & Gas AG.
Agape ATP closes $23M Reg S private placement; issues 46M shares at $0.50
Closed $23M private placement via issuance of 46M shares at $0.50/share to non-U.S. investors on March 24, 2025.
Agape ATP raises $23M private placement; 46M shares at $0.50, shares to increase 12.5x
Sold 46M shares at $0.50 each to 18 non-U.S. institutional investors under Regulation S for $23M.
Agape ATP partners with Formedic to launch LEGA respiratory care device
Collaboration agreement signed Sept 25, 2024, to introduce LEGA, an electronic chest percussion device for airway clearance.
Agape ATP regains Nasdaq minimum bid price compliance after 10 consecutive days above $1.00
Received Nasdaq notice on Sept 17, 2024 confirming compliance with $1 minimum bid price rule.
Agape ATP implements 1-for-20 reverse stock split, cuts authorized shares to 50M
Reverse stock split 1-for-20 effective August 30, 2024; authorized shares reduced from 1B to 50M.
Agape ATP fails to regain bid price compliance; Nasdaq delisting scheduled for July 30; will appeal
Received Nasdaq notice on July 19, 2024, for failing to regain minimum $1 bid price after 180-day period.
Agape ATP subsidiary ATPC Green Energy collaborates with B&H; B&H management gets 30% stake
ATPC Green Energy (wholly owned) signs Collaboration Agreement with B&H Intec Solution Sdn. Bhd.
Agape ATP dismisses Marcum Asia as auditor, hires Assentsure PAC
Board dismissed Marcum Asia CPAs LLP effective April 25, 2024; no disagreements on accounting principles or practices.
On November 15, 2024, Ms. Rose Marie Kadende Kaiser, PhD (“Ms. Rose, PhD) was appointed as an independent director of the Board to fill the vacancy left by Dr Vong, PhD’s resignation.
Dr. Vong, PhD will serve as the Deputy Chairman of the Board following his resignation effective on the same day.
On October 1, 2024, Mr. Chee Chin Aik (“Mr. Chee”) resigned as our independent director of the Board of Directors (the “Board”), the chairman of the nominating and governance committee and as a member of the audit and compensation committees of the Agape ATP Corporation (the “Company”), effective from October 1, 2024.
On October 1, 2024, Dr. Ni Luh Dharma Kerti Natih (Dr. Natih) was appointed as an independent director of the Board to fill the vacancy left by Mr. Chee’s resignation.
Max materiality 0.90 · Median 0.55 · Most common event other_material